Literature DB >> 24526195

Pulmonary hypertension in a pregnant patient with thyrotoxicosis due to Graves' disease: considerations with respect to treatment.

Vanja Mathot1, Erik Oosterwerff, Mariëlle G van Pampus, Robert Riezebos.   

Abstract

A 13 weeks pregnant 24-year-old patient with a history of Graves' disease presented with progressive dyspnoea existing for 4-6 weeks. Blood tests showed severe thyrotoxicosis and transthoracic echocardiography suggested severe pulmonary hypertension (PH) which was thought to be secondary to thyrotoxicosis. PH secondary to thyrotoxicosis is often reversible and may occur 3-14 months after normalisation of free T4 and T3 levels. The maternal mortality risk of PH in pregnancy is high despite modern treatment strategies (17-33%). In this case, PH was carefully monitored for 1 month. No changes in pulmonary artery pressure were found despite immediate treatment with propylthiouracil and β-blockade. We anticipated that the normalisation of pulmonary artery pressure would not occur during this pregnancy and that the risk of complications would remain high. In the interest of the mother an abortion was suggested. Termination of pregnancy took place at the gestational age of 16 weeks.

Entities:  

Mesh:

Year:  2014        PMID: 24526195      PMCID: PMC3926450          DOI: 10.1136/bcr-2013-201916

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

Review 1.  Pulmonary vascular disease and pregnancy: current controversies, management strategies, and perspectives.

Authors:  B M Weiss; O M Hess
Journal:  Eur Heart J       Date:  2000-01       Impact factor: 29.983

2.  Pulmonary hypertension caused by Graves' thyrotoxicosis: normal pulmonary hemodynamics restored by (131)I treatment.

Authors:  I A Nakchbandi; J A Wirth; S E Inzucchi
Journal:  Chest       Date:  1999-11       Impact factor: 9.410

Review 3.  Management of hyperthyroidism in pregnancy.

Authors:  John H Lazarus
Journal:  Endocrine       Date:  2013-10-31       Impact factor: 3.633

Review 4.  Thyrotoxicosis.

Authors:  Jayne A Franklyn; Kristien Boelaert
Journal:  Lancet       Date:  2012-03-05       Impact factor: 79.321

Review 5.  Hyperthyroidism and pulmonary hypertension: an important association.

Authors:  Sailaja Vallabhajosula; Saba Radhi; Cihan Cevik; Raed Alalawi; Rishi Raj; Kenneth Nugent
Journal:  Am J Med Sci       Date:  2011-12       Impact factor: 2.378

6.  Pulmonary arterial hypertension in the setting of pregnancy: a case series and standard treatment approach.

Authors:  J Shaun Smith; Julianne Mueller; Curt J Daniels
Journal:  Lung       Date:  2011-12-03       Impact factor: 2.584

7.  ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC).

Authors:  Vera Regitz-Zagrosek; Carina Blomstrom Lundqvist; Claudio Borghi; Renata Cifkova; Rafael Ferreira; Jean-Michel Foidart; J Simon R Gibbs; Christa Gohlke-Baerwolf; Bulent Gorenek; Bernard Iung; Mike Kirby; Angela H E M Maas; Joao Morais; Petros Nihoyannopoulos; Petronella G Pieper; Patrizia Presbitero; Jolien W Roos-Hesselink; Maria Schaufelberger; Ute Seeland; Lucia Torracca
Journal:  Eur Heart J       Date:  2011-08-26       Impact factor: 29.983

Review 8.  Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension?

Authors:  Elisabeth Bédard; Konstantinos Dimopoulos; Michael A Gatzoulis
Journal:  Eur Heart J       Date:  2009-01-15       Impact factor: 29.983

9.  Pulmonary hypertension responding to hyperthyroidism treatment.

Authors:  Mohamed Osama Hegazi; Amin El Sayed; Hussam El Ghoussein
Journal:  Respirology       Date:  2008-11       Impact factor: 6.424

10.  Pregnancy in women with pulmonary hypertension.

Authors:  P G Pieper; E S Hoendermis
Journal:  Neth Heart J       Date:  2011-12       Impact factor: 2.380

View more
  2 in total

1.  The clinical characteristics and outcomes of patients with pulmonary hypertension in association with hyperthyroid state: A systematic review.

Authors:  Fateen Ata; Adeel Ahmad Khan; Zohaib Yousaf; Hassan Choudry; Areej Marwan Mohammed; Bilal Ahmed; Ahmed Muaaz Umer; Fareeha Khan; Dabia Hamad Sh Al Mohanadi; Emad Naem; Muhammad Zahid
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

2.  Chylous Ascites: A Rare Adverse Effect of Methimazole Treatment for Grave's Disease-A Case Report and Review of the Literature.

Authors:  Tawfik Khoury; Ronen Schneider
Journal:  Case Rep Endocrinol       Date:  2015-08-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.